Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 17/20 | 0.56 |
| ▸ | BCHE | P06276 | 4/20 | 0.56 |
| ▸ | CTSD | P07339 | 13/20 | 0.49 |
| ▸ | BACE2 | Q9Y5Z0 | 12/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3348153 | 0.92 | BACE1 (0.56) | BACE1BCHECTSDBACE2 | |
| SCHEMBL1938153 | 0.86 | BACE1 (0.60) | BACE1BCHECTSDBACE2 | |
| SCHEMBL1938155 | 0.86 | BACE1 (0.60) | BACE1BCHECTSDBACE2 | |
| SCHEMBL27625580 | 0.79 | BCHE (0.41) | BACE1BCHE | |
| SCHEMBL716159 | 0.78 | BACE1 (0.69) | BACE1BCHECTSDBACE2 | |
| SCHEMBL715055 | 0.78 | BACE1 (0.69) | BACE1BCHECTSDBACE2 | |
| SCHEMBL7312407 | 0.76 | BCHE (0.49) | BACE1BCHE | |
| SCHEMBL3016194 | 0.76 | BACE1 (0.58) | BACE1BCHECTSDBACE2 | |
| SCHEMBL3016198 | 0.76 | BACE1 (0.58) | BACE1BCHECTSDBACE2 | |
| SCHEMBL1938012 | 0.76 | BACE1 (0.79) | BACE1BCHECTSDBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9102628-B2 | Derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics | SANOFI (FR) | 2015-08-11 | — | — | US | disclosed |
| US-20100160377-A1 | DERIVATIVES OF PYRAZOLE 3,5-CARBOXYLATES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS | SANOFI-AVENTIS (FR) | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160377-A1 | DERIVATIVES OF PYRAZOLE 3,5-CARBOXYLATES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS | CYP3A5, ADH5, AVPR2 | BACE1 3223/4885BCHE 3099/4885CTSD 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.